RecruitingNot ApplicableNCT06982066

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

Improving Health-Related Quality of Life Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

Sponsor

Connecticut Children's Medical Center

Enrollment

60 participants

Start Date

Feb 10, 2025

Study Type

INTERVENTIONAL

Conditions

Pediatric Cancer Adolescent and Young Adult Cancer

Summary

The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.

Eligibility

Min Age: 15 YearsMax Age: 25 Years

Inclusion Criteria13

Adolescent and Young Adult Oncology Patients
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
Be aged 15-25 years old at time of enrollment.
Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following:
Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy.
Radiotherapy: any radiotherapy to treat the cancer diagnosis.
Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery.
Be greater than or equal to 2 months from diagnosis/initiation of therapy, whichever occurred later.
Be able to speak and read English
Have permission to participate from a member of the patient's primary oncology team.
Provision to sign and date the consent/assent form.
Active study participation of primary oncology clinician
Patient must have primary oncology care at Connecticut Children's Center for Cancer \& Blood Disorders of Children's Hospital Los Angeles Cancer \& Blood Disease Institute

Exclusion Criteria6

An individual who meets and of the following criteria will be excluded from participation in this study:
Not currently on cancer-directed therapy.
Unable to speak and read English.
Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team)
Pediatric Oncology Clinicians
\. Be a pediatric oncology physician, clinical fellow, or advanced practice provider (including nurse practitioners and physician assistants) that provides clinical care for AYA patients with cancer

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALReSPECT

ReSPECT is an interactive, web-based digital platform that integrates (1) an AYA-centered pre-visit questionnaire (PVQ) that will discretely alert clinicians to relevant SRH questions/concerns, (2) targeted patient education on PVQ selections, and (3) clinician-centered guidance for addressing SRH issues. At enrollment, all participants will complete a baseline survey (T1). AYAs will have access to the ReSPECT digital platform and will receive the first prompt to complete the PVQ 3-5 days before their next clinic appointment. Once completed, AYAs will receive an email/text with a link to tailored information based on their PVQ selections for review. Clinicians will receive an email with a link to the patient's PVQ results on the ReSPECT platform along with clinical management recommendations. All participants will complete a brief virtual survey (T2) and interview within 48 hours of the first postintervention clinic visit and a follow-up survey 2 months after study enrollment (T3).